Physician profile

Robert Bryant Mclafferty

Vascular Surgery · Portland, OR

NPI 1295721728

$15,315.76

in general payments reported to CMS, 2019-2025

23 companies · $668 in 2025

The $668 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,343.66
Consulting Fee$700.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $6,975.90 2019-2023 Varithena Administration Pack
Convatec INC. $3,025.00 2021
Endologix LLC $1,400.00 2022-2023 Torus Stent Graft System, Endocross Device
Medtronic, INC. $1,375.32 2022-2025 Venaseal, Endurant Iis
Medtronic Vascular, INC. $426.63 2019-2020
Penumbra, INC. $281.19 2024-2025 Indigo System
Cook Medical LLC $265.56 2022-2023 Zilver Vena
Bard Peripheral Vascular, INC. $239.05 2019-2022
Tactile Systems Technology INC $188.50 2019
Integra Lifesciences Corporation $175.00 2025 Integra, Primatrix, Integra Dermal Regeneration Template
Inspiremd LTD $168.00 2024 Cguard
Inari Medical, INC. $162.49 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Abbott Laboratories $131.16 2022-2024 Esprit
Mimedx Group, INC. $102.79 2024
Amniox Medical, INC. $76.70 2019
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Acera Surgical, INC. $76.64 2025 Restrata Wound Matrix
Abbvie INC. $70.00 2024
Arthrex, INC. $37.00 2023
Teleflex LLC $35.94 2024 Manta
Reapplix INC. $34.85 2022
Biotissue Holdings INC. $28.65 2019
Kerecis Limited $26.40 2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide
Smith+Nephew, INC. $12.99 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Bryant Mclafferty

$15,315.76

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $668 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/330358/robert-bryant-mclafferty

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.